M Pharmaceutical Inc. announced the appointment of Matthew B. Lehman as President and Chief Executive Officer, effective September 1, 2015. Mr. Lehman brings over 15 years of executive level experience in the development of therapeutics to his new role. Dr. Martin Mintchev, the lead inventor of the company's technologies and Company co-founder, will transition from his position as CEO to serve as Chief Scientific Officer.

Most recently, Mr. Lehman was the CEO of Prima Biomed Ltd. As of September 1, 2015, Mr. Lehman will also be appointed to the Company's Board of Directors.